Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, ...

Thatch, the leading platform for modern, flexible health benefits, today announced the launch of the Thatch Marketplace, a curated ecosystem of health and wellness services that employees can access ...

Danish drugmaker Novo Nordisk has announced that it is expanding patient access to Wegovy (semaglutide) injection 2.4 mg in ...

Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.

Gilead held dinners to promote its HIV medications at expensive restaurants that federal authorities claim were “wholly inappropriate” venues, Stat reported. Gilead said it settled to avoid the cost ...

Over the last 7 days, the United States market has risen by 5.2%, contributing to a 9.9% increase over the past 12 months, with earnings forecasted to grow by 14% annually. In this environment, growth ...

After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...

Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer popular ...

PEMBROKE PARK, Fla. – Drugmaker Novo Nordisk announced Tuesday that Wegovy will be available through telehealth providers.

Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...